Page last updated: 2024-09-05

sb 203580 and Delayed Effects, Prenatal Exposure

sb 203580 has been researched along with Delayed Effects, Prenatal Exposure in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, F; Finkel, MS; Hobbs, G; Kan, H1

Other Studies

1 other study(ies) available for sb 203580 and Delayed Effects, Prenatal Exposure

ArticleYear
p38 MAP kinase inhibitor reverses stress-induced myocardial dysfunction in vivo.
    Journal of applied physiology (Bethesda, Md. : 1985), 2009, Volume: 106, Issue:4

    Topics: Adrenergic beta-Agonists; Anesthesia; Animals; Cardiomyopathies; Dose-Response Relationship, Drug; Electrocardiography; Enzyme Inhibitors; Female; Hemodynamics; Imidazoles; Immunoprecipitation; Isoproterenol; Male; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pregnancy; Prenatal Exposure Delayed Effects; Pyridines; Rats; Rats, Sprague-Dawley; Restraint, Physical; Stress, Psychological; Tropomyosin

2009